Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill.
The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year. The ...
Viking Therapeutics highlights VK2735's promising weight loss data at ObesityWeek 2024, with up to 14.7% reduction and ...
There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...
Proposals to offer unemployed people weight loss injections on the NHS may help to address the country’s obesity epidemic, however in order for this to be successful, and safe, it’s vital that ...
As weight-loss injections emerge as key players in the government’s anti-obesity strategy, Emma Loffhagen goes inside the ...
Amgen is focusing deeply on its efforts to treat obesity, the CFO said Wednesday. But Amgen stock dipped a fraction in late trades.
In August the National Pharmacy Association (NPA) urged people not to buy fake weight loss injections. The association warned of a possible 'explosion in the unlicensed sale of medication online ...
A mum almost died after using 'fake' weight loss jabs she purchased for £20 ... But after seeing other people losing weight through injections, Jodi decided to act. She reached out to a ...
Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.
The once-daily pill resulted in only 6.5 per cent ... Despite the rapid development of the weight-loss injection market, there is some concern amongst experts that these drugs could be used ...